The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN. Meeting Abstract

cited authors

  • Chi, Kim N.; Merseburger, Axel S.; Ozguroglu, Mustafa; Chowdhury, Simon; Bjartell, Anders; Chung, Byung; Gomes, Andrea Juliana Pereira de Santana; Given, Robert; Juarez, Alvaro; Uemura, Hirotsugu; Ye, Dingwei; Karsh, Lawrence Ivan; Gartrell, Benjamin Adam; Brookman-May, Sabine D.; Mundle, Suneel; McCarthy, Sharon Anne; Lefresne, Florence; Rooney, Oliver Brendan; Bhaumik, Amitabha; Agarwal, Neeraj

Publication Date

  • February 20, 2022

webpage

published in

category

volume

  • 40

issue

  • 6